Literature DB >> 18790800

Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.

Ester M Orlandi, Fausto Baldanti, Annalisa Citro, Lara Pochintesta, Marta Gatti, Mario Lazzarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18790800     DOI： 10.3324/haematol.13265

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  3 in total

1.  Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma.

Authors:  Nicola Pyatt; Subir Mitra
Journal:  BMJ Case Rep       Date:  2012-07-05

Review 2.  CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Authors:  Emily Blyth; Barbara Withers; Leighton Clancy; David Gottlieb
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

Review 3.  Cytomegalovirus pneumonia in hematopoietic stem cell recipients.

Authors:  Giovanna Travi; Steven A Pergam
Journal:  J Intensive Care Med       Date:  2013-02-06       Impact factor: 3.510
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.